OtherCommentary
Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS) - Through Enhanced Science and Risk-Based Approaches Industry One-Voice-of-Quality (1VQ) Solutions
Emma Ramnarine, Anders Vinther, Kimberly Bruhin, Christina Tovar and Marcello P Colao
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.011734; DOI: https://doi.org/10.5731/pdajpst.2020.011734
Emma Ramnarine
1 Roche;
Anders Vinther
2 Intarcia Therapeutics, Inc.;
Kimberly Bruhin
3 Johnson & Johnson;
Christina Tovar
3 Johnson & Johnson;
Marcello P Colao
4 GSK
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 76, Issue 2
March/April 2022
Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS) - Through Enhanced Science and Risk-Based Approaches Industry One-Voice-of-Quality (1VQ) Solutions
Emma Ramnarine, Anders Vinther, Kimberly Bruhin, Christina Tovar, Marcello P Colao
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.011734; DOI: 10.5731/pdajpst.2020.011734
Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS) - Through Enhanced Science and Risk-Based Approaches Industry One-Voice-of-Quality (1VQ) Solutions
Emma Ramnarine, Anders Vinther, Kimberly Bruhin, Christina Tovar, Marcello P Colao
PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.011734; DOI: 10.5731/pdajpst.2020.011734
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles
Keywords